Neurology coverage across subspecialties.
MS biologics, migraine therapeutics, neurodiagnostics, epilepsy products, and movement disorder devices.
Neurology dynamics.
Neurology has fragmented into a dozen subspecialties — multiple sclerosis, headache medicine, epilepsy, movement disorders, neuromuscular, neuroimmunology, stroke neurology. Each subspecialty has its own evidence base, payer dynamics, and rep buyer profile. The therapeutic landscape has been transformed by biologics (MS), CGRP antagonists (migraine), and gene therapy (rare neurologic disease).
Why this specialty fits Solara reps.
Solara neurology reps are matched by subspecialty rather than generalized — MS, headache, epilepsy, movement disorders each have distinct rep profiles in the network. Per-physician influence in neurology is high and durable.
Apply to the networkWhat Solara delivers for neurology launches.
Manufacturers in neurology need subspecialty-correct rep coverage with the clinical fluency to support biologic and rare-disease product launches. Solara's network covers the major subspecialties with adoption telemetry tuned to each.
Book a working sessionWhat Neurology reps see most.
- ·Multiple sclerosis
- ·Migraine (chronic and episodic)
- ·Epilepsy
- ·Parkinson's disease
- ·Alzheimer's disease
- ·Stroke (acute and secondary prevention)
- ·Neuromuscular diseases (ALS, SMA)
Procedures that anchor the buying motion.
- 95810Polysomnography
- 95812EEG, extended (40-60 min)
- 64612Botulinum toxin injection, facial nerve
- 70551MRI brain without contrast
- 99214Office E/M, established, level 4
Product categories most relevant to neurology.
Common questions about neurology on Solara.
- Does Solara cover specific neurology subspecialties (MS, headache, epilepsy)?
Yes, with subspecialty-aware rep matching. The network covers MS specialists, headache medicine, epilepsy, movement disorders, and neuromuscular as distinct subspecialty workflows. Manufacturers target the specific profile for their product.
- Can Solara support biologic launches with payer-aware messaging?
Yes. Neurology biologics (MS, migraine CGRP antagonists, rare-disease products) have intensive payer-management requirements, and reps are trained on prior-authorization workflows, patient-support resources, and step-therapy navigation.
- How does Solara handle the rare-disease neurology buying motion?
Rare-disease neurology (gene therapy, ASOs for SMA, etc.) is concentrated in centers of excellence with specific protocols and patient-identification workflows. Reps in this area work closely with treatment-center MDs and pharmacy directors.
- What targeting data is used for neurology?
Prescribing patterns by therapeutic class, subspecialty practice patterns, infusion-suite affiliations (for MS and rare disease), and academic-center affiliations. ICP scoring surfaces neurologists with the right patient mix and prescribing density for the specific product.
See your neurology territory.
Drop in your metro on the territory preview tool — we'll surface the top 50 physicians most likely to adopt your product, scored on five signals.